'Hematological disorders pipeline landscape' presentation slideshows

Hypereosinophilic Syndrome Market Future Outlook, Market Growth Analysis-Ken Research

The hypereosinophilic syndrome (HES) is a disease characterized by a persistently elevated eosinophil count (? 1500 eosinophils/mm) in the blood for at least six months without any recognizable cause, with involvement of either the heart, nervous system, or bone marrow. HES is a diagnosis of exclusion, after clonal eosinophilia (such as leukemia) and reactive eosinophilia (in response to infection, autoimmune disease, atopy, hypoadrenalism, tropical eosinophilia, or cancer) have been ruled out. For more information on the research report, visit https://www.kenresearch.com/healthcare/pharmaceuticals/hypereosinophilic-syndrome-pipeline-review-h1-2018/149564-91.html

47 views • 2 slides